Ipamorelin
ipa
Selective growth-hormone secretagogue — clean profile, minimal cortisol/prolactin spike.
- Half-life
- 2 h
- Out of system
- ~10 h
- Route
- Subcutaneous
- Level
- Beginner
Short-acting — protocols usually dose daily. After the last dose, roughly 97% has cleared in ~10 h (five half-lives) — the window that matters for washouts, bloodwork and surgery.
What Ipamorelin is used for
- Selective growth-hormone secretagogue — clean GH pulse
- Minimal cortisol or prolactin spike vs older GHRPs
- Better sleep depth + recovery in self-reported logs
How it's typically used
Research range: 200–300 mcg subcutaneous 1–3× daily, often paired with CJC-1295 No-DAC.
What to watch for
- Effects fade over months — desensitization is real
- Watch glucose if you're prediabetic
- Avoid with active cancer or pituitary tumours
About Performance & GH
- What they are
- Growth-hormone secretagogues and related performance compounds. Rather than supplying GH, they push your pituitary to release more of its own in a pulse.
- How they're run
- Subcutaneous injection, most often at night on an empty stomach so the pulse lands with natural sleep-driven GH release.
- What to watch
- Water retention, tingling hands, and hunger swings are the common early signs. Raising GH raises IGF-1 — worth tracking on bloodwork, and a reason to avoid these with any cancer history.
Full guide
Ipamorelin: A Standalone Tracking Guide
A pragmatic log structure for ipamorelin used on its own, separate from the common CJC-1295 stack.
Other performance & gh
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.